These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35192882)

  • 21. Moxifloxacin HCl-Incorporated Aqueous-Induced Nitrocellulose-Based In Situ Gel for Periodontal Pocket Delivery.
    Senarat S; Rojviriya C; Sarunyakasitrin K; Charoentreeraboon J; Pichayakorn W; Phaechamud T
    Gels; 2023 Jul; 9(7):. PubMed ID: 37504451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo.
    Yuan X; Fei F; Sun H; Xiao C; Zhao X; Zhang Y; Zheng X
    Int J Nanomedicine; 2018; 13():2265-2274. PubMed ID: 29695905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of clove oil in solvent exchange-induced doxycycline hyclate-loaded Eudragit RS
    Phaechamud T; Thurein SM; Chantadee T
    Asian J Pharm Sci; 2018 Mar; 13(2):131-142. PubMed ID: 32104386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solvent exchange and drug release characteristics of doxycycline hyclate-loaded bleached shellac in situ-forming gel and -microparticle.
    Phaechamud T; Senarat S; Puyathorn N; Praphanwittaya P
    Int J Biol Macromol; 2019 Aug; 135():1261-1272. PubMed ID: 30448493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lime Peel Oil-Incorporated Rosin-Based Antimicrobial In Situ Forming Gel.
    Khaing EM; Mahadlek J; Okonogi S; Phaechamud T
    Gels; 2022 Mar; 8(3):. PubMed ID: 35323282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxycycline hyclate-loaded
    Senarat S; Wai Lwin W; Mahadlek J; Phaechamud T
    Saudi Pharm J; 2021 Mar; 29(3):252-263. PubMed ID: 33981174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters.
    Luan X; Bodmeier R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):143-9. PubMed ID: 16243496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility studies of concomitant administration of optimized formulation of probiotic-loaded Vancomycin hydrochloride pellets for colon delivery.
    Avachat AM; Shinde AS
    Drug Dev Ind Pharm; 2016 Jan; 42(1):80-90. PubMed ID: 25923416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo drug release from a novel in situ forming drug delivery system.
    Kranz H; Yilmaz E; Brazeau GA; Bodmeier R
    Pharm Res; 2008 Jun; 25(6):1347-54. PubMed ID: 17968634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
    Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
    Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A transferosome-loaded bigel for enhanced transdermal delivery and antibacterial activity of vancomycin hydrochloride.
    Maji R; Omolo CA; Jaglal Y; Singh S; Devnarain N; Mocktar C; Govender T
    Int J Pharm; 2021 Sep; 607():120990. PubMed ID: 34389419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ forming phase-inversion implants for sustained ocular delivery of triamcinolone acetonide.
    Sheshala R; Hong GC; Yee WP; Meka VS; Thakur RRS
    Drug Deliv Transl Res; 2019 Apr; 9(2):534-542. PubMed ID: 29484530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan coated vancomycin hydrochloride liposomes: Characterizations and evaluation.
    Yang Z; Liu J; Gao J; Chen S; Huang G
    Int J Pharm; 2015 Nov; 495(1):508-515. PubMed ID: 26325316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial Leuprolide Acetate Release from Poly(d,l-lactide-
    Li Z; Mu H; Larsen SW; Jensen H; Østergaard J
    Mol Pharm; 2020 Dec; 17(12):4522-4532. PubMed ID: 33164519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained delivery of amphotericin B and vancomycin hydrochloride by an injectable thermogelling tri-block copolymer.
    Khodaverdi E; Akbari A; Tekie FS; Mohajeri SA; Zohuri G; Hadizadeh F
    PDA J Pharm Sci Technol; 2013; 67(2):135-45. PubMed ID: 23569074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of borneol as an enhancer for targeting aprotinin-conjugated PEG-PLGA nanoparticles to the brain.
    Zhang L; Han L; Qin J; Lu W; Wang J
    Pharm Res; 2013 Oct; 30(10):2560-72. PubMed ID: 23615859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
    Ahmed TA; Ibrahim HM; Samy AM; Kaseem A; Nutan MT; Hussain MD
    AAPS PharmSciTech; 2014 Jun; 15(3):772-80. PubMed ID: 24648158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Durable Antibacterial Cotton Fabrics Based on Natural Borneol-Derived Anti-MRSA Agents.
    Yang L; Zhan C; Huang X; Hong L; Fang L; Wang W; Su J
    Adv Healthc Mater; 2020 Jun; 9(11):e2000186. PubMed ID: 32338449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X; Bodmeier R
    J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Situ
    Haider M; Elsayed I; Ahmed IS; Fares AR
    Pharmaceuticals (Basel); 2021 Jan; 14(1):. PubMed ID: 33466880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.